Skip to content

Chinese Medicine Prevention and Treatment Program for Pre-clinical Rheumatoid Arthritis: An Evidence-based Evaluation Study

Yunpi Qufeng Chushi Granules for Pre-clinical Rheumatoid Arthritis: A Multicenter, Double Blind, Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002430
Enrollment
Unknown
Registered
2019-06-28
Start date
2019-07-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

Sponsors

Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Patients should suffer from >=1 arthritis (joint pain with swelling) and ACPA-positive, but do not meet the classification criteria of 1987 ACR RA classification criteria nor the 2010 ACR/EULAR RA classification criteria or other RA classification criteria; 2) The duration of diseases should last 6 weeks to 6 months; 3) Patients should meet the criteria of the patent of spleen deficiency and blockage of wind and damp; 4) Patients aged 18 to 65 years; 5) Patients will be well informed and agree to participate in this study.

Exclusion criteria

Exclusion criteria: 1) Patients were treated with DMARDs or hydroxychloroquine within 2 months when agreeing to participate in this study; 2) Patients were treated with glucocorticoids; 3) Patients who suffer from severe organ disease or mental illness; 4) Patients who are allergic or have contraindications to the drugs involved in the study.

Design outcomes

Primary

MeasureTime frame
RA transition rate;

Secondary

MeasureTime frame
Patent scores;Simplified disease activity index, SDAI;patient's global assessment ofdisease activity, PGA;Clinical disease activity index, CDAI;physician's global assessment of disease activity, MDGA;Visual Analogue Scale/Score, VAS;

Countries

China

Contacts

Public ContactChengping Wen

Zhejiang Chinese Medical University

wengcp@163.com+86 13757132498

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026